基本信息
views: 8
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
长期从事表观遗传变异所致的转录调控异常参与神经退行性疾病及肿瘤的发生发展的分子机制及干预研究。主持国家自然科学基金3项,广东省自然科学基金1项,广东省高教厅优秀青年创新项目1项,深圳市基础研究项目多项。以第一或通讯作者(含共同)在Molecular Neurodegeneration, Oncogene, Theranostics, Journal of Pathology等国际著名期刊上发表论文20篇。目前担任中国神经科学学会神经内稳态和内分泌分会青年委员,广东省生物物理学会第八届理事会理事。
Research Interests
Papers共 59 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Yongheng Chen,Ying Ying,Wenlong Ma, Hongchao Ma, Liang Shi,Xuefeng Gao,Min Jia,Meiqi Li,Xiaoman Song,Weixiao Kong,Wei Chen,Xiangyi Zheng,
crossref(2024)
Yongheng Chen,Ying Ying,Wenlong Ma, Hongchao Ma, Liang Shi,Xuefeng Gao,Min Jia,Meiqi Li,Xiaoman Song,Weixiao Kong,Wei Chen,Xiangyi Zheng,
crossref(2024)
crossref(2024)
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCHno. 2 (2024): 119655-119655
Yongheng Chen,Ying Ying,Wenlong Ma, Hongchao Ma, Liang Shi,Xuefeng Gao,Min Jia,Meiqi Li,Xiaoman Song,Weixiao Kong,Wei Chen,Xiangyi Zheng,
crossref(2024)
Yongheng Chen,Ying Ying,Wenlong Ma, Hongchao Ma, Liang Shi,Xuefeng Gao,Min Jia,Meiqi Li,Xiaoman Song,Weixiao Kong,Wei Chen,Xiangyi Zheng,
crossref(2024)
Yongheng Chen,Ying Ying,Wenlong Ma, Hongchao Ma, Liang Shi,Xuefeng Gao,Min Jia,Meiqi Li,Xiaoman Song,Weixiao Kong,Wei Chen,Xiangyi Zheng,
crossref(2024)
crossref(2024)
Yongheng Chen,Ying Ying,Wenlong Ma, Hongchao Ma, Liang Shi,Xuefeng Gao,Min Jia,Meiqi Li,Xiaoman Song,Weixiao Kong,Wei Chen,Xiangyi Zheng,
crossref(2024)
Tobias Achu Muluh, Qianqian Fu, Changfeng Wang, Xiaojiao Ai, Wei Chen,Xiangyi Zheng, Wei Wang, Maolin Wang,Xing-Sheng Shu,Ying Ying
Antioxidants & redox signaling (2024)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn